HEADER IMMUNE SYSTEM 26-OCT-04 1XUO TITLE X-RAY STRUCTURE OF LFA-1 I-DOMAIN BOUND TO A 1,4-DIAZEPANE-2,5-DIONE TITLE 2 INHIBITOR AT 1.8A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTEGRIN ALPHA-L; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: I-DOMAIN; COMPND 5 SYNONYM: LEUKOCYTE ADHESION GLYCOPROTEIN LFA-1 ALPHA CHAIN, LFA-1A, COMPND 6 LEUKOCYTE FUNCTION ASSOCIATED MOLECULE 1, ALPHA CHAIN, CD11A; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET17B KEYWDS I-DOMAIN, INTEGRIN, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR S.WATTANASIN,J.KALLEN,S.MYERS,Q.GUO,M.SABIO,C.EHRHARDT,R.ALBERT, AUTHOR 2 U.HOMMEL,G.WECKBECKER,K.WELZENBACH REVDAT 4 20-MAR-24 1XUO 1 COMPND SOURCE REVDAT 3 25-OCT-23 1XUO 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 1XUO 1 VERSN REVDAT 1 26-OCT-05 1XUO 0 JRNL AUTH S.WATTANASIN,J.KALLEN,S.MYERS,Q.GUO,M.SABIO,C.EHRHARDT, JRNL AUTH 2 R.ALBERT,U.HOMMEL,G.WECKBECKER,K.WELZENBACH,G.WEITZ-SCHMIDT JRNL TITL 1,4-DIAZEPANE-2,5-DIONES AS NOVEL INHIBITORS OF LFA-1 JRNL REF BIOORG.MED.CHEM.LETT. V. 15 1217 2005 JRNL REFN ISSN 0960-894X JRNL PMID 15686945 JRNL DOI 10.1016/J.BMCL.2004.11.072 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.9999 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 35097 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1844 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2452 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2120 REMARK 3 BIN FREE R VALUE SET COUNT : 108 REMARK 3 BIN FREE R VALUE : 0.2500 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2866 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 246 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.27000 REMARK 3 B22 (A**2) : -0.75000 REMARK 3 B33 (A**2) : 0.48000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.126 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.118 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.076 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.374 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.942 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2969 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2681 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4001 ; 1.283 ; 1.965 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6275 ; 0.773 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 352 ; 5.734 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 134 ;35.889 ;25.299 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 544 ;13.227 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 6 ;16.618 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 449 ; 0.083 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3221 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 603 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 526 ; 0.205 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2479 ; 0.172 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 1522 ; 0.086 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 172 ; 0.144 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 15 ; 0.174 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 37 ; 0.286 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 13 ; 0.144 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2292 ; 1.246 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 724 ; 0.187 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2864 ; 1.391 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1451 ; 2.210 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1137 ; 3.120 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1XUO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 28-OCT-04. REMARK 100 THE DEPOSITION ID IS D_1000030782. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-JUL-00 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM1A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.80000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35097 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 8.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 7.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06700 REMARK 200 FOR THE DATA SET : 29.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.40000 REMARK 200 FOR SHELL : 4.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: 1CQP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, HEPES, PH 7.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.12950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 71.30800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.99750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 71.30800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.12950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.99750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL ASSEMBLY IS CHAIN A (OR CHAIN B) REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 124 REMARK 465 ALA A 125 REMARK 465 SER A 126 REMARK 465 LYS A 127 REMARK 465 ILE A 309 REMARK 465 GLU A 310 REMARK 465 GLY A 311 REMARK 465 MET B 124 REMARK 465 ALA B 125 REMARK 465 SER B 126 REMARK 465 LYS B 127 REMARK 465 GLN B 303 REMARK 465 LYS B 304 REMARK 465 LYS B 305 REMARK 465 ILE B 306 REMARK 465 TYR B 307 REMARK 465 VAL B 308 REMARK 465 ILE B 309 REMARK 465 GLU B 310 REMARK 465 GLY B 311 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 290 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP B 156 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 174 -107.30 -145.95 REMARK 500 LYS A 190 37.51 39.88 REMARK 500 LEU A 204 -139.36 -123.04 REMARK 500 LEU A 205 -156.24 -95.69 REMARK 500 SER B 174 -101.64 -147.18 REMARK 500 LEU B 204 -138.02 -124.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 312 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER A 139 OG REMARK 620 2 SER A 141 OG 90.0 REMARK 620 3 ASP A 239 OD1 90.6 82.1 REMARK 620 4 GLU A 301 OE2 85.8 90.7 171.9 REMARK 620 5 HOH A 402 O 172.2 90.5 97.2 86.4 REMARK 620 6 HOH A 403 O 87.2 162.6 80.8 106.2 94.6 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 312 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A 404 O REMARK 620 2 HOH A 405 O 85.6 REMARK 620 3 SER B 139 OG 178.0 93.2 REMARK 620 4 SER B 141 OG 87.0 92.7 91.6 REMARK 620 5 ASP B 239 OD1 88.0 172.8 93.1 83.7 REMARK 620 6 HOH B 313 O 94.4 98.5 87.3 168.8 85.3 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 312 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 312 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LA1 A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1CQP RELATED DB: PDB REMARK 900 RELATED ID: 1XDD RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH LFA703 AT 2.2A RESOLUTION REMARK 900 RELATED ID: 1XDG RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH LFA878 AT 2.1A RESOLUTION DBREF 1XUO A 127 311 UNP P20701 ITAL_HUMAN 152 336 DBREF 1XUO B 127 311 UNP P20701 ITAL_HUMAN 152 336 SEQADV 1XUO MET A 124 UNP P20701 CLONING ARTIFACT SEQADV 1XUO ALA A 125 UNP P20701 CLONING ARTIFACT SEQADV 1XUO SER A 126 UNP P20701 CLONING ARTIFACT SEQADV 1XUO TRP A 189 UNP P20701 ARG 214 SEE REMARK 999 SEQADV 1XUO MET B 124 UNP P20701 CLONING ARTIFACT SEQADV 1XUO ALA B 125 UNP P20701 CLONING ARTIFACT SEQADV 1XUO SER B 126 UNP P20701 CLONING ARTIFACT SEQADV 1XUO TRP B 189 UNP P20701 ARG 214 SEE REMARK 999 SEQRES 1 A 188 MET ALA SER LYS GLY ASN VAL ASP LEU VAL PHE LEU PHE SEQRES 2 A 188 ASP GLY SER MET SER LEU GLN PRO ASP GLU PHE GLN LYS SEQRES 3 A 188 ILE LEU ASP PHE MET LYS ASP VAL MET LYS LYS LEU SER SEQRES 4 A 188 ASN THR SER TYR GLN PHE ALA ALA VAL GLN PHE SER THR SEQRES 5 A 188 SER TYR LYS THR GLU PHE ASP PHE SER ASP TYR VAL LYS SEQRES 6 A 188 TRP LYS ASP PRO ASP ALA LEU LEU LYS HIS VAL LYS HIS SEQRES 7 A 188 MET LEU LEU LEU THR ASN THR PHE GLY ALA ILE ASN TYR SEQRES 8 A 188 VAL ALA THR GLU VAL PHE ARG GLU GLU LEU GLY ALA ARG SEQRES 9 A 188 PRO ASP ALA THR LYS VAL LEU ILE ILE ILE THR ASP GLY SEQRES 10 A 188 GLU ALA THR ASP SER GLY ASN ILE ASP ALA ALA LYS ASP SEQRES 11 A 188 ILE ILE ARG TYR ILE ILE GLY ILE GLY LYS HIS PHE GLN SEQRES 12 A 188 THR LYS GLU SER GLN GLU THR LEU HIS LYS PHE ALA SER SEQRES 13 A 188 LYS PRO ALA SER GLU PHE VAL LYS ILE LEU ASP THR PHE SEQRES 14 A 188 GLU LYS LEU LYS ASP LEU PHE THR GLU LEU GLN LYS LYS SEQRES 15 A 188 ILE TYR VAL ILE GLU GLY SEQRES 1 B 188 MET ALA SER LYS GLY ASN VAL ASP LEU VAL PHE LEU PHE SEQRES 2 B 188 ASP GLY SER MET SER LEU GLN PRO ASP GLU PHE GLN LYS SEQRES 3 B 188 ILE LEU ASP PHE MET LYS ASP VAL MET LYS LYS LEU SER SEQRES 4 B 188 ASN THR SER TYR GLN PHE ALA ALA VAL GLN PHE SER THR SEQRES 5 B 188 SER TYR LYS THR GLU PHE ASP PHE SER ASP TYR VAL LYS SEQRES 6 B 188 TRP LYS ASP PRO ASP ALA LEU LEU LYS HIS VAL LYS HIS SEQRES 7 B 188 MET LEU LEU LEU THR ASN THR PHE GLY ALA ILE ASN TYR SEQRES 8 B 188 VAL ALA THR GLU VAL PHE ARG GLU GLU LEU GLY ALA ARG SEQRES 9 B 188 PRO ASP ALA THR LYS VAL LEU ILE ILE ILE THR ASP GLY SEQRES 10 B 188 GLU ALA THR ASP SER GLY ASN ILE ASP ALA ALA LYS ASP SEQRES 11 B 188 ILE ILE ARG TYR ILE ILE GLY ILE GLY LYS HIS PHE GLN SEQRES 12 B 188 THR LYS GLU SER GLN GLU THR LEU HIS LYS PHE ALA SER SEQRES 13 B 188 LYS PRO ALA SER GLU PHE VAL LYS ILE LEU ASP THR PHE SEQRES 14 B 188 GLU LYS LEU LYS ASP LEU PHE THR GLU LEU GLN LYS LYS SEQRES 15 B 188 ILE TYR VAL ILE GLU GLY HET MG A 312 1 HET LA1 A 401 40 HET MG B 312 1 HETNAM MG MAGNESIUM ION HETNAM LA1 (2R)-2-[3-ISOBUTYL-2,5-DIOXO-4-(QUINOLIN-3-YLMETHYL)-1, HETNAM 2 LA1 4-DIAZEPAN-1-YL]-N-METHYL-3-(2-NAPHTHYL)PROPANAMIDE HETSYN LA1 (S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL- HETSYN 2 LA1 [1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL- HETSYN 3 LA1 PROPIONAMIDE FORMUL 3 MG 2(MG 2+) FORMUL 4 LA1 C33 H36 N4 O3 FORMUL 6 HOH *246(H2 O) HELIX 1 1 GLN A 143 LEU A 161 1 19 HELIX 2 2 ASP A 182 LYS A 190 1 9 HELIX 3 3 ASP A 191 LEU A 196 1 6 HELIX 4 4 ASN A 207 VAL A 219 1 13 HELIX 5 5 ARG A 221 GLY A 225 5 5 HELIX 6 6 ILE A 248 LYS A 252 5 5 HELIX 7 7 LYS A 263 GLN A 266 5 4 HELIX 8 8 THR A 267 LEU A 274 1 8 HELIX 9 9 HIS A 275 PHE A 277 5 3 HELIX 10 10 PRO A 281 PHE A 285 1 5 HELIX 11 11 GLU A 293 GLN A 303 1 11 HELIX 12 12 LYS A 304 ILE A 306 5 3 HELIX 13 13 GLN B 143 LEU B 161 1 19 HELIX 14 14 ASP B 182 LYS B 190 1 9 HELIX 15 15 ASP B 191 LEU B 196 1 6 HELIX 16 16 ASN B 207 VAL B 219 1 13 HELIX 17 17 ARG B 221 GLY B 225 5 5 HELIX 18 18 ILE B 248 LYS B 252 5 5 HELIX 19 19 LYS B 263 GLN B 266 5 4 HELIX 20 20 THR B 267 THR B 273 1 7 HELIX 21 21 LEU B 274 ALA B 278 5 5 HELIX 22 22 PRO B 281 PHE B 285 1 5 HELIX 23 23 THR B 291 GLU B 293 5 3 HELIX 24 24 LYS B 294 GLU B 301 1 8 SHEET 1 A 6 TYR A 177 PHE A 181 0 SHEET 2 A 6 TYR A 166 PHE A 173 -1 N GLN A 172 O LYS A 178 SHEET 3 A 6 VAL A 130 ASP A 137 1 N PHE A 134 O VAL A 171 SHEET 4 A 6 THR A 231 THR A 238 1 O ILE A 235 N LEU A 135 SHEET 5 A 6 ILE A 255 ILE A 261 1 O ILE A 259 N ILE A 236 SHEET 6 A 6 VAL A 286 LEU A 289 1 O LEU A 289 N GLY A 260 SHEET 1 B 6 TYR B 177 PHE B 181 0 SHEET 2 B 6 TYR B 166 PHE B 173 -1 N ALA B 170 O GLU B 180 SHEET 3 B 6 VAL B 130 ASP B 137 1 N PHE B 134 O VAL B 171 SHEET 4 B 6 THR B 231 THR B 238 1 O VAL B 233 N VAL B 133 SHEET 5 B 6 ILE B 255 ILE B 261 1 O ILE B 259 N ILE B 236 SHEET 6 B 6 VAL B 286 LEU B 289 1 O LYS B 287 N ILE B 258 LINK OG SER A 139 MG MG A 312 1555 1555 2.16 LINK OG SER A 141 MG MG A 312 1555 1555 2.03 LINK OD1 ASP A 239 MG MG A 312 1555 1555 2.18 LINK OE2 GLU A 301 MG MG A 312 3545 1555 2.05 LINK MG MG A 312 O HOH A 402 1555 1555 2.09 LINK MG MG A 312 O HOH A 403 1555 1555 2.02 LINK O HOH A 404 MG MG B 312 1555 1555 2.10 LINK O HOH A 405 MG MG B 312 1555 1555 2.12 LINK OG SER B 139 MG MG B 312 1555 1555 2.20 LINK OG SER B 141 MG MG B 312 1555 1555 2.07 LINK OD1 ASP B 239 MG MG B 312 1555 1555 2.09 LINK MG MG B 312 O HOH B 313 1555 1555 2.06 CISPEP 1 LYS A 280 PRO A 281 0 -2.25 CISPEP 2 LYS B 280 PRO B 281 0 6.53 SITE 1 AC1 6 SER A 139 SER A 141 ASP A 239 GLU A 301 SITE 2 AC1 6 HOH A 402 HOH A 403 SITE 1 AC2 6 HOH A 404 HOH A 405 SER B 139 SER B 141 SITE 2 AC2 6 ASP B 239 HOH B 313 SITE 1 AC3 10 PHE A 153 TYR A 166 TYR A 257 LEU A 302 SITE 2 AC3 10 LYS A 305 ILE A 306 VAL A 308 HOH A 486 SITE 3 AC3 10 MET B 140 LEU B 203 CRYST1 46.259 59.995 142.616 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021617 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016668 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007012 0.00000 CONECT 90 2869 CONECT 104 2869 CONECT 905 2869 CONECT 1551 2910 CONECT 1565 2910 CONECT 2366 2910 CONECT 2869 90 104 905 2911 CONECT 2869 2912 CONECT 2870 2871 CONECT 2871 2870 2872 2874 CONECT 2872 2871 2873 CONECT 2873 2872 CONECT 2874 2871 2875 2886 CONECT 2875 2874 2876 CONECT 2876 2875 2877 2885 CONECT 2877 2876 2878 CONECT 2878 2877 2879 2883 CONECT 2879 2878 2880 CONECT 2880 2879 2881 CONECT 2881 2880 2882 CONECT 2882 2881 2883 CONECT 2883 2878 2882 2884 CONECT 2884 2883 2885 CONECT 2885 2876 2884 CONECT 2886 2874 2887 2897 CONECT 2887 2886 2888 CONECT 2888 2887 2889 CONECT 2889 2888 2890 2891 CONECT 2890 2889 CONECT 2891 2889 2892 2899 CONECT 2892 2891 2893 2897 CONECT 2893 2892 2894 CONECT 2894 2893 2895 2896 CONECT 2895 2894 CONECT 2896 2894 CONECT 2897 2886 2892 2898 CONECT 2898 2897 CONECT 2899 2891 2900 CONECT 2900 2899 2901 2909 CONECT 2901 2900 2902 CONECT 2902 2901 2903 2907 CONECT 2903 2902 2904 CONECT 2904 2903 2905 CONECT 2905 2904 2906 CONECT 2906 2905 2907 CONECT 2907 2902 2906 2908 CONECT 2908 2907 2909 CONECT 2909 2900 2908 CONECT 2910 1551 1565 2366 2913 CONECT 2910 2914 3051 CONECT 2911 2869 CONECT 2912 2869 CONECT 2913 2910 CONECT 2914 2910 CONECT 3051 2910 MASTER 358 0 3 24 12 0 7 6 3154 2 55 30 END